| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hanmi Pharmaceutical Co., Ltd. | 20% | $115,375 | 508,710 | Hanmi Pharmaceutical Co., Ltd. | 18 Mar 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$4,414 | 0 | |
| 2024 Q4 | 19,592 | $4,414 | +$4,393 | $0.23 | 2 |
| 2024 Q3 | 92 | $38 | $0.41 | 1 | |
| 2024 Q2 | 92 | $70 | -$44,000 | $0.76 | 1 |
| 2024 Q1 | 26,758 | $44,153 | -$79,202 | $1.66 | 2 |
| 2023 Q4 | 74,758 | $188,234 | $2.53 | 2 | |
| 2023 Q3 | 74,758 | $209,258 | +$59,717 | $2.80 | 2 |
| 2023 Q2 | 53,424 | $247,427 | -$16,354,051 | $4.64 | 2 |
| 2023 Q1 | 20,962,406 | $13,416,873 | -$1,028,939 | $0.64 | 44 |
| 2022 Q4 | 22,970,643 | $13,320,850 | -$985,663 | $0.58 | 48 |
| 2022 Q3 | 24,557,699 | $14,615,453 | -$318,301 | $0.60 | 47 |
| 2022 Q2 | 25,058,806 | $18,646,507 | -$2,734,410 | $0.74 | 43 |
| 2022 Q1 | 28,531,682 | $38,807,613 | -$3,580,687 | $1.36 | 51 |
| 2021 Q4 | 31,179,158 | $42,369,792 | -$20,800,165 | $1.35 | 57 |
| 2021 Q3 | 39,570,451 | $86,350,850 | -$22,510,362 | $2.18 | 63 |
| 2021 Q2 | 47,225,004 | $156,739,083 | -$38,364,376 | $3.32 | 62 |
| 2021 Q1 | 52,369,697 | $312,930,503 | +$27,233,992 | $5.98 | 71 |
| 2020 Q4 | 48,718,160 | $213,602,858 | -$10,658,227 | $4.38 | 65 |
| 2020 Q3 | 46,407,177 | $278,292,363 | +$62,519,881 | $6.00 | 64 |
| 2020 Q2 | 35,924,634 | $226,542,479 | +$5,200,153 | $6.31 | 57 |
| 2020 Q1 | 34,928,326 | $207,138,467 | +$26,188,083 | $5.94 | 52 |
| 2019 Q4 | 30,725,365 | $174,227,455 | +$81,216,464 | $5.67 | 56 |
| 2019 Q3 | 14,207,658 | $29,579,615 | +$4,633,211 | $2.08 | 31 |
| 2019 Q2 | 11,921,350 | $31,121,540 | +$22,562,599 | $2.61 | 29 |
| 2019 Q1 | 3,295,238 | $6,621,532 | +$429,262 | $2.00 | 21 |
| 2018 Q4 | 3,093,398 | $5,909,239 | +$3,413,791 | $1.91 | 20 |
| 2018 Q3 | 1,240,646 | $3,226,577 | +$974,193 | $2.60 | 16 |
| 2018 Q2 | 846,761 | $3,289,881 | +$1,457,654 | $3.94 | 22 |
| 2018 Q1 | 479,837 | $1,515,652 | +$466,220 | $3.17 | 16 |
| 2017 Q4 | 365,569 | $817,067 | +$418,875 | $2.24 | 15 |
| 2017 Q3 | 177,400 | $263,585 | -$1,105,838 | $1.48 | 11 |
| 2017 Q2 | 1,088,212 | $1,338,627 | -$1,369,601 | $1.23 | 7 |
| 2017 Q1 | 2,435,040 | $2,477,698 | -$373,142 | $1.03 | 10 |
| 2016 Q4 | 2,688,809 | $3,664,000 | -$283,788 | $1.40 | 11 |
| 2016 Q3 | 2,899,922 | $6,532,018 | +$885,330 | $2.25 | 10 |
| 2016 Q2 | 2,504,257 | $6,161,020 | -$322,238 | $2.44 | 10 |
| 2016 Q1 | 2,628,108 | $7,734,020 | -$22,658 | $2.95 | 12 |
| 2015 Q4 | 2,633,101 | $6,766,012 | -$502,487 | $2.54 | 10 |
| 2015 Q3 | 2,751,269 | $11,960,000 | -$2,117,621 | $4.31 | 12 |
| 2015 Q2 | 3,132,610 | $16,322,000 | +$1,360,898 | $5.10 | 15 |
| 2015 Q1 | 2,921,962 | $15,775,000 | -$1,285,757 | $5.42 | 13 |
| 2014 Q4 | 3,158,681 | $18,681,000 | +$18,658,000 | $5.92 | 7 |